© 2021 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
May 08, 2021
May 07, 2021
May 06, 2021
May 05, 2021
A multi-part panel discussion centered around management of lipid disorders in 2021 led by Practical Cardiology Advisory Board members.
May 04, 2021
Dr. Paul Thompson reflects on the results of recent N-of-1 studies examining the effects of statin therapy on muscle pain and offers his perspective on the conclusions drawn by these trials.
May 03, 2021
The American Heart Association and American Stroke Association have released a special report related to the treatment of blood clots or low platelet counts related to the COVID-19 vaccine, which has garnered mass amounts of attention despite being a rare complication.
May 02, 2021
Results of 1-year follow-up from the Harmony TPV Clinical trial provide insight into the safety and efficacy of the recently approved Harmony TPV system in patients with congenital heart disease and severe pulmonary regurgitation.
April 30, 2021
The US FDA announced dapagliflozin (Farxiga) received approval for reducing the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression in a statement on April 30.
An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.